Found: 28
Select item for more details and to access through your institution.
Health-related Quality of Life and Satisfaction with German Health Care Services in Patients with Charcot-Marie-Tooth Neuropathy.
- Published in:
- Journal of Neuromuscular Diseases, 2022, v. 9, n. 1, p. 211, doi. 10.3233/JND-210667
- By:
- Publication type:
- Article
Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 1, p. 110, doi. 10.3390/brainsci13010110
- By:
- Publication type:
- Article
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 5, p. 1049, doi. 10.1002/acn3.51340
- By:
- Publication type:
- Article
Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 5, p. 757, doi. 10.1002/acn3.51042
- By:
- Publication type:
- Article
Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00735
- By:
- Publication type:
- Article
Heterozygous DHTKD1 Variants in Two European Cohorts of Amyotrophic Lateral Sclerosis Patients.
- Published in:
- Genes, 2022, v. 13, n. 1, p. 84, doi. 10.3390/genes13010084
- By:
- Publication type:
- Article
Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfaction.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03562-x
- By:
- Publication type:
- Article
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 7, p. 3616, doi. 10.1007/s00415-023-11711-4
- By:
- Publication type:
- Article
An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 3, p. 950, doi. 10.1007/s00415-020-10227-5
- By:
- Publication type:
- Article
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 8, p. 2398, doi. 10.1007/s00415-020-09847-8
- By:
- Publication type:
- Article
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 7, p. 2130, doi. 10.1007/s00415-020-09799-z
- By:
- Publication type:
- Article
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 1, p. 36, doi. 10.1007/s00415-019-09547-y
- By:
- Publication type:
- Article
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 9, p. 1437, doi. 10.1002/acn3.51645
- By:
- Publication type:
- Article
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 3, p. 367, doi. 10.3390/brainsci11030367
- By:
- Publication type:
- Article
Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 3, p. 296, doi. 10.3390/brainsci11030296
- By:
- Publication type:
- Article
Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 1, p. 8, doi. 10.3390/brainsci11010008
- By:
- Publication type:
- Article
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286421998902
- By:
- Publication type:
- Article
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286421998902
- By:
- Publication type:
- Article
Disease burden of spinal muscular atrophy in Germany.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 441, doi. 10.1186/s13023-014-0210-9
- By:
- Publication type:
- Article
Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31617-5
- By:
- Publication type:
- Article
Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metabolic syndrome is common in adults with 5q‐spinal muscular atrophy and impacts quality of life and fatigue.
- Published in:
- Muscle & Nerve, 2024, v. 70, n. 2, p. 257, doi. 10.1002/mus.28183
- By:
- Publication type:
- Article
Differential expression and localization of Ankrd2 isoforms in human skeletal and cardiac muscles.
- Published in:
- Histochemistry & Cell Biology, 2016, v. 146, n. 5, p. 569, doi. 10.1007/s00418-016-1465-0
- By:
- Publication type:
- Article
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 8, p. 2582, doi. 10.1111/ene.14902
- By:
- Publication type:
- Article
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy.
- Published in:
- 2021
- By:
- Publication type:
- journal article